179 related articles for article (PubMed ID: 9037208)
41. Mechanism of glucocorticoid induction of the rat plasminogen activator inhibitor-1 gene in HTC rat hepatoma cells: identification of cis-acting regulatory elements.
Bruzdzinski CJ; Johnson MR; Goble CA; Winograd SS; Gelehrter TD
Mol Endocrinol; 1993 Sep; 7(9):1169-77. PubMed ID: 8247019
[TBL] [Abstract][Full Text] [Related]
42. Effects of chronic phorbol ester treatment on protein kinase C activity, content, and gene expression in the human monoblastoid U937 cell.
Ways DK; Qin W; Garris TO; Chen J; Hao E; Cooper DR; Usala SJ; Parker PJ; Cook PP
Cell Growth Differ; 1994 Feb; 5(2):161-9. PubMed ID: 8180129
[TBL] [Abstract][Full Text] [Related]
43. On the role of c-Jun in the induction of PAI-1 gene expression by phorbol ester, serum, and IL-1alpha in HepG2 cells.
Arts J; Grimbergen J; Toet K; Kooistra T
Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):39-46. PubMed ID: 9888864
[TBL] [Abstract][Full Text] [Related]
44. Post-transcriptional stabilization of urokinase plasminogen activator mRNA by 2,3,7,8-tetrachlorodibenzo-p-dioxin in a human keratinocyte cell line.
Gaido KW; Maness SC
Toxicol Appl Pharmacol; 1995 Jul; 133(1):34-42. PubMed ID: 7597708
[TBL] [Abstract][Full Text] [Related]
45. MEKK1 regulates the AP-1 dimer repertoire via control of JunB transcription and Fra-2 protein stability.
Cuevas BD; Uhlik MT; Garrington TP; Johnson GL
Oncogene; 2005 Jan; 24(5):801-9. PubMed ID: 15558021
[TBL] [Abstract][Full Text] [Related]
46. TCDD-inducible plasminogen activator inhibitor type 2 (PAI-2) in human hepatocytes, HepG2 and monocytic U937 cells.
Gohl G; Lehmköster T; Münzel PA; Schrenk D; Viebahn R; Bock KW
Carcinogenesis; 1996 Mar; 17(3):443-9. PubMed ID: 8631129
[TBL] [Abstract][Full Text] [Related]
47. Southwestern blot mapping of potential regulatory proteins binding to the DNA encoding plasminogen activator inhibitor type 2.
Antalis TM; Godbolt D; Donnan KD; Stringer BW
Gene; 1993 Dec; 134(2):201-8. PubMed ID: 8262378
[TBL] [Abstract][Full Text] [Related]
48. Identification of urokinase-type plasminogen activator receptor in human endothelial cells and its modulation by phorbol myristate acetate.
Matsumoto H; Ueshima S; Fukao H; Mitsui Y; Matsuo O
Cell Struct Funct; 1995 Dec; 20(6):429-37. PubMed ID: 8825063
[TBL] [Abstract][Full Text] [Related]
49. Src induces urokinase receptor gene expression and invasion/intravasation via activator protein-1/p-c-Jun in colorectal cancer.
Leupold JH; Asangani I; Maurer GD; Lengyel E; Post S; Allgayer H
Mol Cancer Res; 2007 May; 5(5):485-96. PubMed ID: 17510314
[TBL] [Abstract][Full Text] [Related]
50. Role of LFB3 in cell-specific cAMP induction of the urokinase-type plasminogen activator gene.
Marksitzer R; Stief A; Menoud PA; Nagamine Y
J Biol Chem; 1995 Sep; 270(37):21833-8. PubMed ID: 7665606
[TBL] [Abstract][Full Text] [Related]
51. UVB increases urokinase-type plasminogen activator receptor (uPAR) expression.
Marschall C; Lengyel E; Nobutoh T; Braungart E; Douwes K; Simon A; Magdolen V; Reuning U; Degitz K
J Invest Dermatol; 1999 Jul; 113(1):69-76. PubMed ID: 10417621
[TBL] [Abstract][Full Text] [Related]
52. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.
Tabengwa EM; Grenett HE; Benza RL; Abou-Agag LH; Tresnak JK; Wheeler CG; Booyse FM
Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828
[TBL] [Abstract][Full Text] [Related]
53. Induction of plasminogen activator inhibitor 1 biosynthesis by hyperthermia.
Bergonzelli GE; Kruithof EK
J Cell Physiol; 1991 Aug; 148(2):306-13. PubMed ID: 1652590
[TBL] [Abstract][Full Text] [Related]
54. [Effect of cyclic AMP and phorbol ester on PAI-2 synthesis in a leukemic cell line PL-21 and on u-PA secretion in a pre-B cell lymphoma cell line RC-K8].
Niiya K; Sakuragawa N
Nihon Rinsho; 1992 Feb; 50(2):325-9. PubMed ID: 1319513
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of invasion of HT1080 sarcoma cells expressing recombinant plasminogen activator inhibitor 2.
Laug WE; Cao XR; Yu YB; Shimada H; Kruithof EK
Cancer Res; 1993 Dec; 53(24):6051-7. PubMed ID: 8261421
[TBL] [Abstract][Full Text] [Related]
56. Cell-type specific DNA-protein interactions at the tissue-type plasminogen activator promoter in human endothelial and HeLa cells in vivo and in vitro.
Arts J; Herr I; Lansink M; Angel P; Kooistra T
Nucleic Acids Res; 1997 Jan; 25(2):311-7. PubMed ID: 9016559
[TBL] [Abstract][Full Text] [Related]
57. Monocytic cell type-specific transcriptional induction of collagenase.
Pierce RA; Sandefur S; Doyle GA; Welgus HG
J Clin Invest; 1996 Apr; 97(8):1890-9. PubMed ID: 8621773
[TBL] [Abstract][Full Text] [Related]
58. [Expression and significance of urokinase-type plasminogen activator, its receptor, and type 2 inhibitor in giant cell tumor of bone].
Li H; Dong S; Zeng Y
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):386-8. PubMed ID: 11810768
[TBL] [Abstract][Full Text] [Related]
59. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.
Stephens RW; Pöllänen J; Tapiovaara H; Leung KC; Sim PS; Salonen EM; Rønne E; Behrendt N; Danø K; Vaheri A
J Cell Biol; 1989 May; 108(5):1987-95. PubMed ID: 2523891
[TBL] [Abstract][Full Text] [Related]
60. A regulatory element that mediates co-operation between a PEA3-AP-1 element and an AP-1 site is required for phorbol ester induction of urokinase enhancer activity in HepG2 hepatoma cells.
Nerlov C; De Cesare D; Pergola F; Caracciolo A; Blasi F; Johnsen M; Verde P
EMBO J; 1992 Dec; 11(12):4573-82. PubMed ID: 1330539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
